Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
DMO is a leading cause of visual loss in people with diabetes and requires prompt ophthalmological intervention, often with intravitreal injections or laser therapy
Significant weight loss from GLP-1 therapy may reduce levothyroxine requirements in some patients
We would also like to sincerely thank our patients and their guardians for participation in the study
It takes only a few minutes to begin
Cells were washed three times with Krebs buffer (20 mM HEPES, 5 mM KH 2 PO 4 , 1 mM MgSO 4 , 1 mM CaCl 2 , 136 mM NaCl, 4.7 mM KCl, pH 7.4), then incubated with 500 g/ml 2-NBDG, a fluorescence-labeled deoxyglucose analog, for 20 min at room temperature
US$ 23.52
US$ 21.68
US$ 21.60
US$ 24.81
US$ 21.76
US$ 21.99
